title: [Update on current care guidelines. Prolonged epileptic attack].
authors.forename: Reeta
authors.initials: R
authors.lastname: Kälviäinen
authors.forename: Ilona
authors.initials: I
authors.lastname: Autti-Rämö
authors.forename: Kai
authors.initials: K
authors.lastname: Eriksson
authors.forename: Olli
authors.initials: O
authors.lastname: Häppölä
authors.forename: Tapani
authors.initials: T
authors.lastname: Keränen
authors.forename: Jaana
authors.initials: J
authors.lastname: Kuoppala
authors.forename: Jouni
authors.initials: J
authors.lastname: Kurola
authors.forename: Anna-Leena
authors.initials: AL
authors.lastname: Kuusela
authors.forename: Eero
authors.initials: E
authors.lastname: Mervaala
authors.forename: Tapani
authors.initials: T
authors.lastname: Salmi
authors.forename: Minna
authors.initials: M
authors.lastname: Tallgren
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D004632:Emergency Medical Services; D005260:Female; D005387:Finland; D006801:Humans; D007262:Infusions, Intravenous; D008140:Lorazepam / Q000008:administration & dosage; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D010634:Phenobarbital / Q000008:administration & dosage; D010672:Phenytoin / Q000008:administration & dosage; D018570:Risk Assessment; D012720:Severity of Illness Index; D013226:Status Epilepticus / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D010672:Phenytoin; D008140:Lorazepam; D003975:Diazepam; D010634:Phenobarbital